Abstract

Carvedilol 1.25-mg/mL Oral Suspension

Author(s): Allen Loyd V Jr

Issue: May/Jun 2006 - Hormone Replacement Therapy

Page(s): 220

Download in electronic PDF format for $75
  • Carvedilol 1.25-mg/mL Oral Suspension Page 1

Abstract

A formulation for preparing Carvedilol 1.25-mg/mL Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • carvedilol
  • nonselective beta adrenergic blocking agent
  • nonselective beta blocker
  • hypertension
  • high blood pressure
  • congestive heart failure
  • heart disease
  • cardiovascular disorders
  • antihypertensive agent

Related Categories

  • FORMULATIONS
  • CARDIOLOGY
  • NEUROLOGY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
May/Jun 2006
Pg. 220
Carvedilol 1.25-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Sep/Oct 2011
Pg. 418
Carvedilol 0.625-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Mar/Apr 2016
Pg. 145
Carvedilol 3.125-mg, 6.25-mg, 12.5 mg, or 25-mg capsules
Author(s): Allen Loyd V Jr
Sep/Oct 2010
Pg. 423
Carvedilol 1-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Mar/Apr 2010
Pg. 108-111
Coenzyme Q10 Supplementation in the Treatment of Heart Disease
Author(s): Bramwell Bethany L
Sep/Oct 2009
Pg. 367-371
Congestive Heart Failure and Other Medical Facts About Ferrets; Scout's Story: A Case Report on Treating Congestive Heart Failure in a Ferret
Author(s): Williams LaVonn A, Riley Kari
May/Jun 2020
Pg. 194-197
Compounded Beta-blocker Nasal Spray for Treatment of Acute Migraine: A New Therapeutic Modality
Author(s): Hagan John C III, Everett Eric, Chamberlain Tyler
Nov/Dec 2021
Pg. 503
Metoprolol Tartrate 10 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Sep/Oct 2022
Pg. 364-368
A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans
Author(s): Riepl Mike
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Sep/Oct 2011
Pg. 421
Metoprolol Tartrate 1.25-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Jul/Aug 2013
Pg. 333
Metoprolol Tartrate 1-mg/mL Injection
Author(s): Allen Loyd V Jr
Mar/Apr 2005
Pg. 117-119
Combating Cardiovascular Disease With Compounded Medications. Part 1: Combination Cardiac Medicines to Control Blood Pressure
Author(s): Harrington Catherine A, Cauffield Jacintha
Nov/Dec 2012
Pg. 513-515
Stability of Propranolol Hydrochloride in SyrSpend SF
Author(s): Geiger Christine M, Voudrie Mark A II, Sorenson Bridget
Jul/Aug 2014
Pg. 330
Propranolol Hydrochloride 1-mg/mL Injection
Author(s): Allen Loyd V Jr
May/Jun 2006
Pg. 227
Quinapril 1-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Nov/Dec 2021
Pg. 504
Propranolol 2 mg/mL or 5 mg/mL in Ora-Sweet
Author(s): Allen Loyd V Jr
Mar/Apr 2022
Pg. 148
Propranolol 2 mg/mL and 5 mg/mL in Ora-Blend SF Suspension
Author(s): Allen Loyd V Jr
Nov/Dec 2017
Pg. 496
Spironolactone 5 mg/mL in SuspendIt Oral Suspension
Author(s): Allen Loyd V Jr
Jul/Aug 2018
Pg. 325
Propranolol Hydrochloride 1 mg/mL in SyrSpend SF Oral Suspension
Author(s): Allen Loyd V Jr